Rallye in Biontech shares extends as European Medicines Agency has accelerated approval process for a Covid-19 vaccine developed by Germany's BioNTech & Pfizer, to allow for the rapid authorisation of the shot as soon as safety data from its trial allows. #CoronavirusOutbreak# #Eurozone# #StockMarket#
风险提示：本文所述仅代表作者个人观点，不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证，对于基于该内容所采取的任何行为，不承担任何责任，除非另有书面明确说明。
暂无评论。 来发表第一条观点吧。